Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.4B | 7.6B | 9.9B | 7.7B |
| Cost of revenue | 5.0B | 6.1B | 7.5B | 6.0B |
| Gross profit | 1.4B | 1.5B | 2.4B | 1.7B |
| Operating expense | ||||
| Research & development | — | 85.5M | 93.1M | 110.9M |
| Selling general and admin | 2.0B | 491.1M | 354.0M | 394.8M |
| Other operating expenses | — | 414.2M | 323.5M | -33.8M |
| Operating income | 1.4B | -740.5M | 466.6M | 55.4M |
| Non operating interest income | ||||
| Income | — | 1.6B | 1.7B | 1.7B |
| Expense | — | 1.3B | 1.5B | 1.4B |
| Other income expense | — | — | — | — |
| Pretax income | -1.6B | -13.3B | 1.3B | -3.3B |
| Tax provision | -102.3M | -2.1B | 99.0M | 426.6M |
| Net income | -1.5B | -11.3B | 1.2B | -3.7B |
| Basic EPS | -118.1 | — | 109 | -339 |
| Diluted EPS | -118.1 | — | 109 | -339 |
| Basic average shares | — | — | 11.2M | 10.9M |
| Diluted average shares | — | — | 11.2M | 10.9M |
| EBITDA | 1.4B | -10.5B | 3.5B | -2.8B |
| Net income from continuing op. | — | -11.3B | 1.2B | -3.7B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |